Allen C. Sherman, PhD, MA

Research Program: Cancer Prevention and Population Sciences Faculty Rank: Professor, Director Behavioral Medicine Division Campus: University of Arkansas for Medical Sciences College: College of Medicine Department: Otolaryngology

Cancer Research Interest

• Disease Site Focus: Head and Neck, Breast, Multiple Myeloma, Gynecology
• Research Focus Area: Health Disparities, Prevention, Treatment, Detection
• Research Keywords: psychosocial oncology, quality-of-life, patient-reported outcomes, survivorship, heatlh disparities, screening and detection
• Type of Research: Clinical, Population Sciences
• Research Interest Statement: My research has focused on psychosocial oncology. As director of the Behavioral Medicine division research lab at the cancer institute, I have served as principal investigator on a large series of projects regarding quality-of-life outcomes and survivorship, as well as development of patient-reported outcome measures, and interventions for psychosocial morbidity. Other interests have included health disparities in cancer screening and prevention. I have been particularly interested in psychosocial factors associated with risk or resilience for patients with diverse malignancies. Our programmatic investigations in these areas have been widely recognized (including work at the forefront of research regarding religious involvement and health outcomes in oncology). Most of these projects have been propelled by interdisciplinary teams at UAMS or have involved national or international collaborations with other investigators.

Contact Information

• Email Address: shermanallenc@uams.edu
• Profiles Research Networking Software: View Profile

Publications

• Singer S, Hammerlid E, Tomaszewska IM, [et al., including Sherman AC]. Methodological approach for determining the Minimal Important Difference and Minimal Important Change scores for the European Organisation for Research and Treatment of Cancer Head and Neck Cancer Module (EORTC QLQ-HN43) exemplified by the Swallowing scale. Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation. 2021. PMID: 34272632.
• Sherman AC, Park CL, Salsman JM, [et al.]. Anxiety, depressive, and trauma symptoms during the COVID-19 pandemic: Evaluating the role of disappointment with God. Journal of affective disorders. 2021 293:245-253. PMID: 34217962.
• Sherman AC, Simonton-Atchley S, O'Brien CE, [et al.]. Associations Between Religious/Spiritual Coping and Depression Among Adults with Cystic Fibrosis: A 12-Month Longitudinal Study. Journal of religion and health. 2021. PMID: 33575892.
• McLouth LE, Ford CG, Pustejovsky JE, [et al., including Sherman AC]. A systematic review and meta-analysis of effects of psychosocial interventions on spiritual well-being in adults with cancer. Psycho-oncology. 2021 30(2):147-158. PMID: 34602807. PMCID: PMC8485897.
• Sherman AC, Williams ML, Amick BC, [et al.]. Mental health outcomes associated with the COVID-19 pandemic: Prevalence and risk factors in a southern US state. Psychiatry research. 2020 293:113476. PMID: 33198047. PMCID: PMC7513769.
• Sherman AC, Simonton-Atchley S, O'Brien CE, [et al.]. Longitudinal associations between gratitude and depression 1 year later among adult cystic fibrosis patients. Journal of behavioral medicine. 2020 43(4):596-604. PMID: 31254218.
• Park CL, Pustejovsky JE, Trevino K, [et al., including Sherman AC]. Effects of psychosocial interventions on meaning and purpose in adults with cancer: A systematic review and meta-analysis. Cancer. 2019 125(14):2383-2393. PMID: 31034600. PMCID: PMC6602826.
• Sherman AC, Simonton-Atchley S, Campbell D, [et al.]. Persistent Adherence to Airway Clearance Therapy in Adults With Cystic Fibrosis. Respiratory care. 2019 64(7):778-785. PMID: 30890632.
• Singer S, Amdal CD, Hammerlid E, [et al., including Sherman AC]. International validation of the revised European Organisation for Research and Treatment of Cancer Head and Neck Cancer Module, the EORTC QLQ-HN43: Phase IV. Head & neck. 2019 41(6):1725-1737. PMID: 30636188.
• Sherman AC, Simonton-Atchley S, Mikeal CW, [et al.]. Cancer patient perspectives regarding preparedness for end-of-life care: A qualitative study. Journal of psychosocial oncology. 2018 36(4):454-469. PMID: 29863447.
• Salsman JM, Pustejovsky JE, Park CL, [et al., including Sherman AC]. Reply to the association between religion/spirituality and mental health in cancer. Cancer. 2016 122(15):2441-2. PMID: 27197776. PMCID: PMC5537719.
• Sherman AC, Merluzzi TV, Pustejovsky JE, [et al.]. A meta-analytic review of religious or spiritual involvement and social health among cancer patients. Cancer. 2015 121(21):3779-88. PMID: 26258730. PMCID: PMC4618183.
• Jim HS, Pustejovsky JE, Park CL, [et al., including Sherman AC]. Religion, spirituality, and physical health in cancer patients: A meta-analysis. Cancer. 2015 121(21):3760-8. PMID: 26258868. PMCID: PMC4618080.
• Park CL, Sherman AC, Jim HS, Salsman JM. Religion/spirituality and health in the context of cancer: Cross-domain integration, unresolved issues, and future directions. Cancer. 2015 121(21):3789-94. PMID: 26258608. PMCID: PMC4618033.
• Salsman JM, Pustejovsky JE, Jim HS, [et al., including Sherman AC]. A meta-analytic approach to examining the correlation between religion/spirituality and mental health in cancer. Cancer. 2015 121(21):3769-78. PMID: 26258536. PMCID: PMC4618157.
• Salsman JM, Fitchett G, Merluzzi TV, [et al., including Sherman AC]. Religion, spirituality, and health outcomes in cancer: A case for a meta-analytic investigation. Cancer. 2015 121(21):3754-9. PMID: 26258400. PMCID: PMC4618242.
• Singer S, Araújo C, Arraras JI, [et al., including Sherman AC]. Measuring quality of life in patients with head and neck cancer: Update of the EORTC QLQ-H&N Module, Phase III. Head & neck. 2015 37(9):1358-67. PMID: 24832623.